Nyra Medical is developing a first-in-class trans-catheter native leaflet augmenting repair (TLAR) device, the cardiac leaflet enhancer (CARLEN), to correct mitral and tricuspid regurgitation. Our approach preserves the physiological valve geometry while restoring its function, eliminates the risk of stenosis, and is forward compatible with all future interventions.